Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Riera

Showing results (231-240 of 245) with videos related to

Pageof 25
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2010
Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapyJ Cobo, L Garcia San Miguel, G Euba, et al.
Circulation|April 1, 2009
Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stressO Tornavaca, G Pascual, M L Barreiro, et al.
HIV Medicine|November 23, 2012
Metformin: a cheap and well-tolerated drug that provides benefits for viral infectionsJ Joven, J A Menéndez, L Fernandez-Sender, et al.
HIV Medicine|December 10, 2013
Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapyG Sampériz, D Guerrero, M López, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2016
Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)J A Perez-Molina, R Rubio, A Rivero, et al.
International Journal of Obesity (2005)|March 29, 2014
Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver diseaseE Rodríguez-Gallego, M Guirro, M Riera-Borrull, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 15, 2005
[GESIDA/SEFH/PNS recommendations to improve adherence to antiretroviral therapy in 2004]I Escobar, H Knobel, R Polo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 28, 2011
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infectionE Cordero, T Aydillo, M C Fariñas, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2012
Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS CohortC Manzardo, A Esteve, N Ortega, et al.
The Journal of Infection|June 24, 2008
HIV-1 infected patients older than 50 years. PISCIS cohort studyG Navarro, M M Nogueras, F Segura, et al.
Pageof 25

Showing results (231-240 of 245) with videos related to

Sort By:
Pageof 25
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2010
Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapyJ Cobo, L Garcia San Miguel, G Euba, et al.
Circulation|April 1, 2009
Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stressO Tornavaca, G Pascual, M L Barreiro, et al.
HIV Medicine|November 23, 2012
Metformin: a cheap and well-tolerated drug that provides benefits for viral infectionsJ Joven, J A Menéndez, L Fernandez-Sender, et al.
HIV Medicine|December 10, 2013
Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapyG Sampériz, D Guerrero, M López, et al.
The Journal of Antimicrobial Chemotherapy|September 16, 2016
Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)J A Perez-Molina, R Rubio, A Rivero, et al.
International Journal of Obesity (2005)|March 29, 2014
Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver diseaseE Rodríguez-Gallego, M Guirro, M Riera-Borrull, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 15, 2005
[GESIDA/SEFH/PNS recommendations to improve adherence to antiretroviral therapy in 2004]I Escobar, H Knobel, R Polo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 28, 2011
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infectionE Cordero, T Aydillo, M C Fariñas, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2012
Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS CohortC Manzardo, A Esteve, N Ortega, et al.
The Journal of Infection|June 24, 2008
HIV-1 infected patients older than 50 years. PISCIS cohort studyG Navarro, M M Nogueras, F Segura, et al.
Pageof 25